The Food and Drug Administration Feb. 5 released an alert notifying patients of a safety concern using diabetes devices such ...

The first direction Tuesday was given by Stefanie Spear, a deputy chief of staff at HHS who joined the agency this week, according to the Post. Spear was the press secretary for Robert F.

The memo, which was sent to agency leaders by acting HHS Secretary Dorothy Fink, outlines that the HHS agencies should refrain from sending any documents for publication in the Federal Register ...

Kennedy Jr., President-elect Donald Trump’s pick for HHS secretary, undergoes Senate confirmation. Kennedy’s confirmation hearings are still not scheduled, and he is facing bipartisan pressure ...

The Trump administration has put a freeze on many federal health agency communications with the public through at least the end of the month. In a memo obtained by The Associated Press, acting ...

Diabetes can lead to complications throughout the body and commonly causes digestive disorders such as gastroparesis (delayed emptying of the stomach). This can lead to stomach problems and pain.

During Trump's first administration, prior to the overturning of Roe v. Wade, HHS took actions to reduce abortion, including reinstating and expanding a policy that bars foreign non-government ...

TUESDAY, Jan. 21, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to ...

The Washington Post: Trump Team Taps Dorothy Fink To Serve As Interim HHS Secretary Incoming Trump officials have tapped Dorothy Fink, an endocrinologist and career civil servant, as the interim ...

In most cases, people with type 2 diabetes can drink alcohol in moderate amounts. As you may well know, living with type 2 diabetes often means cutting out or cutting back on foods and beverages that ...

Unfortunately, there are no randomized prospective studies that have evaluated the optimal site of care for either DKA or HHS. Given the lack of such studies, the decision concerning the site of ...

No­var­tis is the lat­est drug­mak­er to sue the gov­ern­ment for al­leged­ly re­ject­ing its pro­posed mod­el to dis­trib­ute fed­er­al drug dis­counts.